ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.932,17
-1,10%
S&P 500
5.035,69
-1,57%
Dow Jones
37.815,92
-1,49%
Euro vs US Dollar
1,06732
-0,40%
Bitcoin
59.745,99
-6,41%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Marinus Pharmaceuticals Inc (MRNS)

  7. Marinus Pharmaceuticals Inc (MRNS) News

MRNS Marinus Pharmaceuticals Inc

1,41
0,01 (0,71%)
Nach Börsenschluss
Zuletzt aktualisiert: 22:03:11
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Marinus Pharmaceuticals Inc MRNS NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,01 0,71% 1,41 22:03:11
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,42 1,39 1,43 1,41 1,40
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
15.4.202413:00BWMarinus Pharmaceuticals Provides Update on the Phase 3 RAISE..
05.4.202422:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
27.3.202413:41BWMarinus Pharmaceuticals Comments on Patent Challenge by Ovid..
05.3.202422:14EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05.3.202422:01BWMarinus Pharmaceuticals Provides Business Update and Reports..
22.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202413:00BWMarinus Pharmaceuticals to Present at Upcoming Investor..
20.2.202413:00BWMarinus Pharmaceuticals to Provide Business Update and..
16.2.202422:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
14.2.202422:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202421:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202418:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202416:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202415:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202418:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19.1.202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202422:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
04.1.202413:04EDGAR2Form 8-K - Current report
04.1.202413:01BWMarinus Pharmaceuticals Reports Preliminary Fourth Quarter..
07.12.202322:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
28.11.202313:05EDGAR2Form 8-K - Current report
20.11.202322:01BWMarinus Pharmaceuticals Announces Seven Presentations at AES..
14.11.202322:05BWMarinus Pharmaceuticals to Present at the 6th Annual..
09.11.202322:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
07.11.202313:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202313:11EDGAR2Form 8-K - Current report
07.11.202313:01BWMarinus Pharmaceuticals Provides Business Update and Reports..
07.11.202313:00BWMarinus Pharmaceuticals Initiates Global Access Program for..
24.10.202313:01BWMarinus Pharmaceuticals to Provide Business Update and..
10.10.202322:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06.10.202322:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
28.9.202313:05EDGAR2Form 8-K - Current report
21.9.202322:00BWMarinus Pharmaceuticals to Present at the 2023 Cantor Global..
19.9.202314:02EDGAR2Form 8-K - Current report
19.9.202314:00BWMarinus Pharmaceuticals Highlights Advancing Pipeline and..
12.9.202322:00BWMarinus Pharmaceuticals Announces Speakers for Hybrid..
06.9.202322:01BWMarinus Pharmaceuticals Announces Inducement Grants Under..

Kürzlich von Ihnen besucht

NASDAQ
MRNS
Marinus Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten